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ScienceDirect
journal homepage: www.e- jmii .comCORRESPONDENCEMalakoplakia in a patient with complicated
urinary tract infection caused by extended-
spectrum b-lactamase-producing Escherichia
coliDear Editor,
With great interest, we read the article by Pacheco et al1 in
the Journal of Microbiology, Immunology and Infection,
which reported that multidrug-resistant, extended-spec-
trum b-lactamase (ESBL)-producing Escherichia coli is an
important pathogen in nosocomial urinary tract infection,
causing great concern in therapeutic failure. Here, we
report a patient who was diagnosed with complicated uri-
nary tract infection caused by ESBL-producing E. coli and
complicating obstructive uropathy by malakoplakia. We
performed multiple-site biopsies of the bladder and ureter
to verify the diagnosis and observed MichaeliseGutmann
bodies microscopically, which is the characteristic of
malakoplakia. It is a challenge for the clinician for man-
aging such a case infected with emerging resistant strains
complicating with malakoplakia.
This 83-year-old male patient had a history of rectal
adenocarcinoma, stage T3N0M0, status postoperation, and
chemotherapy. He was suffering from fever, left flank pain,
and dysuria on admission. The results of the laboratory data
were as follows: hemoglobin, 10.6 mg/dL; white blood cells
count, 14,800 cells/mL; and platelet count, 178,000 cells/
mL. The urine routine examinations showed pyuria and
bacteriuria. He empirically received antibiotic therapy with
1-g cefazolin intravenous (iv) drip every 8 hours. The image
study of abdominal sonogram revealed left-sided hydro-
nephrosis. The percutaneous nephrostomy plus antegrade
pyelography showed hydronephrosis and dilatation of the
lower third ureter (Fig. 1A). Endoscopic findings of the
bladder and ureter showed some soft yellowish tumor-like
plaques over the bladder and ureter mucosa. The patho-
logical findings of biopsy and resection specimens revealed1684-1182/$36 Copyright ª 2014, Taiwan Society of Microbiology. Publ
http://dx.doi.org/10.1016/j.jmii.2013.12.001the typical finding of malakoplakia (Fig. 1B). His fever
persisted even after the 3-day cefazolin therapy. However,
the urine culture revealed ESBL-producing E. coli with a
multidrug resistant strain, but susceptible to carbapenems.
Therefore, his cefazolin therapy was discontinued and 1-g
iv drip of ertapenem was administered every day for a
complete 7-day therapeutic course. A follow-up visit with
cystoscopic examination revealed that his condition was
resolved with urologic surgical intervention and the com-
plete course of antibiotics therapy.
Malakoplakia is a uncommon tumor-like xanthogranu-
lomatous disease that occurs commonly in the urinary
tract, followed by the gastrointestinal tract.2e4 The clinical
manifestation of urinary tract malakoplakia is diverse, from
asymptomatic to chronic cystitis, pyelonephritis, renal
mass-like lesion, and complicated with obstructive
uropathy.2e4 Endoscopically, malakoplakia commonly pre-
sents with soft yellow to gray polyp-like lesions.2 Histo-
pathologically, it is characterized by distinctive Michaelis-
Gutmann bodies and with positive von Kossa staining.3
The etiology and pathogenesis of malakoplakia is still not
fully understood, but multiple possible mechanisms have
suggested that it may be related to chronic infection. The
common organisms included E. coli, Proteus, Mycobacte-
rium tuberculosis, and Staphylococcus aureus.2e4 The
macrophages or histiocytes incompletely digest microor-
ganisms accumulated in lysosomes, leading to the miner-
alization of calcium and iron salts deposited in the
cytoplasm and emulating biofilm formation, which is diffi-
cult to treat.5 The MichaeliseGutmann bodies of malako-
plakia can be highlighted by the Periodic acideSchiff (PAS)
for iron and von Kossa stain for calcium, and this is the
diagnostic characteristic (Fig. 1B).ished by Elsevier Taiwan LLC. All rights reserved.
Figure 1. (A) Percutaneous nephrostomy and antegrade pyelography reveals the obstruction of the lower third ureter with
hydronephrosis and hydroureter. (B) Pathology of the urinary tract mucosa shows malakoplakia (Michaelis-Gutmann bodies; arrow)
in some of the histiocytes as rounded, concentrically-layered inclusions. The inset picture shows positive staining for calcium by
von Kossa stain (original magnification 400).
346 CorrespondenceThe treatment of malakoplakia involves antibiotics
therapy and/or surgical resection.2e4 If it is a susceptible
pathogen, the antibiotics trimethoprim/sulphamethox-
azole, rifampicin, and ciprofloxacin are the drugs of choice
for biofilm-related organisms5 because these drugs have
good penetration into macrophages and contribute to
intracellular bacteria death. For a multidrug-resistant
microorganism such as ESBL-producing E. coli, carbape-
nems antibiotics plus surgical resection may be an alter-
native therapy.
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